Caricamento...

Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis

INTRODUCTION: Semaglutide, a new treatment option approved for the treatment of patients with type 2 diabetes mellitus, is a glucagon-like peptide-1 receptor agonist to be injected subcutaneously once weekly. This analysis used a population pharmacokinetic model of semaglutide to identify clinically...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diabetes Ther
Autori principali: Carlsson Petri, Kristin Cecilie, Ingwersen, Steen Hvass, Flint, Anne, Zacho, Jeppe, Overgaard, Rune Viig
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Healthcare 2018
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6064581/
https://ncbi.nlm.nih.gov/pubmed/29907893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-018-0458-5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !